P3 Health Partners (PIII) Competitors $0.20 +0.01 (+4.72%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PIII vs. PSNL, LFMD, BDSX, EUDA, QIPT, XGN, BNR, ENZ, CCM, and TOIShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Personalis (PSNL), LifeMD (LFMD), Biodesix (BDSX), EUDA Health (EUDA), Quipt Home Medical (QIPT), Exagen (XGN), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), Concord Medical Services (CCM), and Oncology Institute (TOI). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Personalis LifeMD Biodesix EUDA Health Quipt Home Medical Exagen Burning Rock Biotech Enzo Biochem Concord Medical Services Oncology Institute Personalis (NASDAQ:PSNL) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Do institutionals and insiders hold more shares of PSNL or PIII? 61.9% of Personalis shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 4.1% of Personalis shares are held by insiders. Comparatively, 17.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend PSNL or PIII? Personalis currently has a consensus target price of $7.31, indicating a potential upside of 27.17%. P3 Health Partners has a consensus target price of $2.38, indicating a potential upside of 1,103.75%. Given P3 Health Partners' higher possible upside, analysts plainly believe P3 Health Partners is more favorable than Personalis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Personalis 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00P3 Health Partners 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is PSNL or PIII more profitable? P3 Health Partners has a net margin of -6.95% compared to Personalis' net margin of -104.52%. Personalis' return on equity of -66.07% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets Personalis-104.52% -66.07% -41.34% P3 Health Partners -6.95%-71.31%-11.93% Does the media favor PSNL or PIII? In the previous week, Personalis had 10 more articles in the media than P3 Health Partners. MarketBeat recorded 11 mentions for Personalis and 1 mentions for P3 Health Partners. Personalis' average media sentiment score of 0.33 beat P3 Health Partners' score of 0.00 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 0 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings and valuation, PSNL or PIII? P3 Health Partners has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPersonalis$87.49M4.64-$108.30M-$1.68-3.42P3 Health Partners$1.48B0.05-$57.77M-$0.84-0.23 Does the MarketBeat Community prefer PSNL or PIII? Personalis received 113 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 66.86% of users gave Personalis an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote. CompanyUnderperformOutperformPersonalisOutperform Votes11766.86% Underperform Votes5833.14% P3 Health PartnersOutperform Votes426.67% Underperform Votes1173.33% Which has more risk and volatility, PSNL or PIII? Personalis has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. SummaryPersonalis beats P3 Health Partners on 10 of the 18 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIII vs. The Competition Export to ExcelMetricP3 Health PartnersHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$70.80M$867.07M$5.13B$9.08BDividend YieldN/A1.90%4.91%4.22%P/E Ratio-0.2332.2091.4117.18Price / Sales0.053.751,113.85116.83Price / Cash2.3625.1442.7137.86Price / Book0.442.924.794.78Net Income-$57.77M-$5.79M$120.07M$225.60M7 Day Performance-3.76%-4.93%-1.91%-1.23%1 Month Performance-10.15%-4.89%11.46%3.36%1 Year Performance-83.28%226.77%30.54%16.59% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIP3 Health Partners2.3874 of 5 stars$0.20+4.7%$2.38+1,103.8%-83.0%$70.80M$1.48B-0.23500News CoveragePSNLPersonalis3.9661 of 5 stars$3.79-0.8%$6.81+79.7%+293.8%$267.76M$73.48M-2.27400Analyst ForecastNews CoverageGap UpLFMDLifeMD1.4049 of 5 stars$5.73+0.7%$11.57+101.9%-37.0%$248.18M$193.06M-8.89230Positive NewsBDSXBiodesix2.56 of 5 stars$1.34-0.4%$3.06+129.2%-4.8%$194.20M$65.56M-3.44220EUDAEUDA Health0.3167 of 5 stars$5.42-9.1%N/A+246.2%$133.48M$3.81M0.002QIPTQuipt Home Medical2.5539 of 5 stars$3.06+1.7%$6.25+104.2%-49.5%$131.86M$221.74M-27.361,200Earnings ReportAnalyst RevisionNews CoverageXGNExagen4.6619 of 5 stars$6.03+4.3%$7.00+16.1%+191.0%$106.37M$52.55M-6.14220High Trading VolumeBNRBurning Rock Biotech1.9752 of 5 stars$6.75+0.3%N/A-12.3%$69.15M$510.89M-2.241,390Positive NewsENZEnzo Biochem0.7816 of 5 stars$1.02flatN/A-46.7%$53.29M$31.91M0.00520Earnings ReportAnalyst ForecastCCMConcord Medical Services0.3784 of 5 stars$4.89-1.2%N/A-58.8%$21.23M$471.70M0.00970Analyst ForecastNews CoverageTOIOncology Institute2.5295 of 5 stars$0.21-5.8%$2.50+1,090.5%-88.1%$15.87M$378.93M-0.29660 Related Companies and Tools Related Companies PSNL Competitors LFMD Competitors BDSX Competitors EUDA Competitors QIPT Competitors XGN Competitors BNR Competitors ENZ Competitors CCM Competitors TOI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PIII) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
